Summit Therapeutics Inc (SMMT)

Mar 12, 2026

WINTON GROUP Ltd Makes New Investment in Summit Therapeutics PLC $SMMT - MarketBeat

Mar 12, 2026

Mar 12, 2026

Understanding the Setup: (SMMT) and Scalable Risk - Stock Traders Daily

Mar 12, 2026

Mar 11, 2026

Summit Therapeutics at The Citizens Life Sciences Conference: Strategic Insights on Ivonescimab - Investing.com Nigeria

Mar 11, 2026

Mar 11, 2026

Earnings Report: Is Summit Therapeutics Inc impacted by rising ratesQuarterly Portfolio Review & Free Daily Entry Point Trade Alerts - baoquankhu1.vn

Mar 11, 2026

Mar 09, 2026

Earnings Recap: How correlated is Summit Therapeutics Inc to the S P5002026 Outlook & Reliable Entry Point Alerts - baoquankhu1.vn

Mar 09, 2026

Mar 07, 2026

Summit Therapeutics (NASDAQ:SMMT) Upgraded by Zacks Research to Hold Rating - MarketBeat

Mar 07, 2026

Mar 06, 2026

Summit Therapeutics PLC (NASDAQ:SMMT) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Mar 06, 2026

Mar 06, 2026

Summit Therapeutics (NASDAQ:SMMT) Gains Market Visibility On Nasdaq Today - Kalkine Media

Mar 06, 2026

Mar 05, 2026

Aug Outlook: Can Summit Therapeutics Inc stock outperform in a bear marketDollar Strength & Risk Managed Investment Entry Signals - baoquankhu1.vn

Mar 05, 2026

Mar 04, 2026

Why Summit Therapeutics (SMMT) Is Down 6.3% After Wider 2025 Loss and ESOP Shelf Filing - simplywall.st

Mar 04, 2026

Mar 03, 2026

Is Summit Therapeutics (SMMT) Now Pricing In Too Much Hope After Strong Multi Year Gains - simplywall.st

Mar 03, 2026

Mar 03, 2026

Rafferty Asset Management LLC Purchases 140,323 Shares of Summit Therapeutics PLC $SMMT - MarketBeat

Mar 03, 2026

Mar 03, 2026

Is Summit Therapeutics (SMMT) Pricing Reflect Long Term Value After Recent Share Price Swings - Yahoo Finance

Mar 03, 2026

Mar 03, 2026

Summit Therapeutics (SMMT) Ends 2025 With Strong Cash Reserves and Increased Clinical Investment - Finviz

Mar 03, 2026

Mar 03, 2026

10 Stocks With Explosive Growth Potential - Insider Monkey

Mar 03, 2026

Mar 03, 2026

Summit Therapeutics at TD Cowen Conference: Strategic Focus on Ivonesimab - Investing.com

Mar 03, 2026

Mar 02, 2026

SMMT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 02, 2026

Mar 02, 2026

Summit Therapeutics Inc. (SMMT) Stock Analysis: Biotech Innovator with an 89.92% Potential Upside - DirectorsTalk Interviews

Mar 02, 2026

Mar 02, 2026

Vanguard Group Inc. Purchases 2,706,056 Shares of Summit Therapeutics PLC $SMMT - MarketBeat

Mar 02, 2026

Mar 02, 2026

Summit Therapeutics Inc. (SMMT) Focused on Non-Small Cell Lung Cancer Trial of Ivonescimab - Insider Monkey

Mar 02, 2026

Mar 01, 2026

The Technical Signals Behind (SMMT) That Institutions Follow - Stock Traders Daily

Mar 01, 2026

Feb 28, 2026

11 Best Cancer Stocks to Invest In Now - Insider Monkey

Feb 28, 2026

Feb 27, 2026

Summit Therapeutics Inc.Common Stock (NQ: SMMT - FinancialContent

Feb 27, 2026

Feb 27, 2026

Q1 EPS Estimate for Summit Therapeutics Increased by Analyst - MarketBeat

Feb 27, 2026

Feb 26, 2026

Summit Therapeutics to Present at Upcoming Investor Conferences - Business Wire

Feb 26, 2026

Feb 26, 2026

Wells Fargo Keeps Their Buy Rating on Summit Therapeutics (SMMT) - The Globe and Mail

Feb 26, 2026

Feb 25, 2026

How Summit’s Deeper 2025 Loss and Ivonescimab’s FDA Path At Summit Therapeutics (SMMT) Has Changed Its Investment Story - simplywall.st

Feb 25, 2026

Feb 25, 2026

Summit Therapeutics Inc. (NASDAQ:SMMT) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 25, 2026

Feb 25, 2026

H.C. Wainwright cuts Summit Therapeutics stock price target on China trial timing uncertainty - Investing.com Australia

Feb 25, 2026

Feb 25, 2026

Summit Therapeutics Shares Slip Following Mixed Results from Lung Cancer Trial - MSN

Feb 25, 2026

Feb 25, 2026

Analysts Are Neutral on These Healthcare Stocks: Pliant Therapeutics (PLRX), Summit Therapeutics (SMMT) - The Globe and Mail

Feb 25, 2026

Feb 24, 2026

Summit Therapeutics Inc (SMMT) Q4 2025 Earnings Call Highlights: Strong Cash Position and ... By GuruFocus - Investing.com Canada

Feb 24, 2026

Feb 24, 2026

Summit Therapeutics Inc (SMMT) Q4 2025 Earnings Call Highlights: - GuruFocus

Feb 24, 2026

Feb 24, 2026

Earnings Call Summary | Summit Therapeutics(SMMT.US) Q4 2025 Earnings Conference - 富途牛牛

Feb 24, 2026

Feb 24, 2026

SMMT: Analyst Lowers Price Target to $30, Maintains Buy Rating | - GuruFocus

Feb 24, 2026

Feb 24, 2026

SMMT Incurs Wider-Than-Expected Q4 Loss, Pipeline Progress in Focus - Finviz

Feb 24, 2026

Feb 24, 2026

Traders Purchase High Volume of Put Options on Summit Therapeutics (NASDAQ:SMMT) - MarketBeat

Feb 24, 2026

Feb 24, 2026

Assessing Summit Therapeutics (SMMT) Valuation After Recent Share Price Swings - simplywall.st

Feb 24, 2026

Feb 24, 2026

Summit Therapeutics Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Feb 24, 2026

Feb 24, 2026

HC Wainwright Has Lowered Expectations for Summit Therapeutics (NASDAQ:SMMT) Stock Price - MarketBeat

Feb 24, 2026

Feb 24, 2026

SMMT: Analyst Lowers Price Target to $30, Maintains Buy Rating | SMMT Stock News - GuruFocus

Feb 24, 2026

Feb 24, 2026

Summit Therapeutics (SMMT) Q4 Earnings Miss Expectations - GuruFocus

Feb 24, 2026

Feb 24, 2026

Summit Therapeutics (SMMT) Set for Potential Upside Ahead of Key Data Release - GuruFocus

Feb 24, 2026

Feb 24, 2026

Summit Therapeutics (SMMT) Highlights Progress in Cancer Drug De - GuruFocus

Feb 24, 2026

Feb 24, 2026

Summit Therapeutics (SMMT) Is Up 7.6% After Steep Losses And New US$102 Million Shelf RegistrationHas The Bull Case Changed? - Yahoo Finance

Feb 24, 2026

Feb 24, 2026

Decoding Summit Therapeutics Inc (SMMT): A Strategic SWOT Insigh - GuruFocus

Feb 24, 2026

Feb 23, 2026

Earnings call transcript: Summit Therapeutics Q4 2025 reports significant EPS miss - Investing.com Nigeria

Feb 23, 2026

Feb 23, 2026

Summit Therapeutics Q4 Earnings Call Highlights - MarketBeat

Feb 23, 2026

Feb 23, 2026

Summit Therapeutics (SMMT) Updates on HARMONi-3 Trial Progress - GuruFocus

Feb 23, 2026

Feb 23, 2026

Summit Therapeutics falls on earnings miss despite progress By Investing.com - Investing.com South Africa

Feb 23, 2026

Feb 23, 2026

Summit Therapeutics falls on earnings miss despite progress - Investing.com

Feb 23, 2026

Feb 23, 2026

Summit Therapeutics Reports 2025 Results, Advances Ivonescimab Programs - TipRanks

Feb 23, 2026